[go: up one dir, main page]

GB1302671A - - Google Patents

Info

Publication number
GB1302671A
GB1302671A GB4009571A GB4009571A GB1302671A GB 1302671 A GB1302671 A GB 1302671A GB 4009571 A GB4009571 A GB 4009571A GB 4009571 A GB4009571 A GB 4009571A GB 1302671 A GB1302671 A GB 1302671A
Authority
GB
United Kingdom
Prior art keywords
aerosol
aug
propellant
vaccines
dispersing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4009571A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1302671A publication Critical patent/GB1302671A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

1302671 Aerosol vaccines PHILIPS GLOEILAMPENFABRIEKEN NV 26 Aug 1971 [29 Aug 1970] 40095/71 Heading C4X [Also in Division A5] Aerosol vaccines are prepared by dispersing dry antigen in a liquid aerosol propellant using lecithin as dispersing agent. The propellant may be a mixture of dichlorodifluoromethane and trichlorofluoromethane.
GB4009571A 1970-08-29 1971-08-26 Expired GB1302671A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7012832A NL7012832A (en) 1970-08-29 1970-08-29

Publications (1)

Publication Number Publication Date
GB1302671A true GB1302671A (en) 1973-01-10

Family

ID=19810895

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4009571A Expired GB1302671A (en) 1970-08-29 1971-08-26

Country Status (7)

Country Link
US (1) US3755557A (en)
BE (1) BE771918A (en)
CA (1) CA971480A (en)
DE (1) DE2141289A1 (en)
FR (1) FR2103608B1 (en)
GB (1) GB1302671A (en)
NL (1) NL7012832A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550706A1 (en) * 1983-08-17 1985-02-22 Sterwin Ag
GB2170815A (en) * 1985-02-05 1986-08-13 Sterwin Ag Aerosol compositions
EP1592443A4 (en) * 2003-02-13 2007-02-21 Becton Dickinson Co Improved anthrax vaccines and delivery methods

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
FR2423217A2 (en) * 1978-03-10 1979-11-16 Anvar Administration of myxomatosis vaccine - by inhalation of aerosol or nasal instillation
US4223014A (en) * 1978-05-08 1980-09-16 The United States Of America As Represented By The Secretary Of The Interior Spray immunization of fish
DE2966914D1 (en) * 1978-09-14 1984-05-24 Gist Brocades Nv Combined vaccine active against newcastle disease and egg production drop caused by adeno-like viruses, process for preparing it, adeno-like and newcastle disease virus strains
US4225583A (en) * 1978-12-07 1980-09-30 Iowa State University Research Foundation, Inc. Intra-respiratory vaccine for prevention of Bordetella bronchiseptica infection and method of use
NL7812359A (en) * 1978-12-20 1980-06-24 Gist Brocades Nv VACCINES AGAINST REAL VIRUS DISEASE SYMPTOMS AND METHOD FOR PREPARING THESE VACCINES.
NL8102786A (en) * 1981-06-10 1983-01-03 Duphar Int Res METHOD FOR IMMUNIZING PIGS AGAINST AUJESZKY'S DISEASE
JPS59163313A (en) * 1983-03-09 1984-09-14 Teijin Ltd Peptide hormone composition for nasal administration
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
ATE78158T1 (en) * 1985-05-22 1992-08-15 Liposome Technology Inc METHOD AND SYSTEM FOR INHALATION OF LIPOSOMES.
WO1992010208A1 (en) * 1990-12-04 1992-06-25 Microtek Research And Development Ltd. Spray-dried antigenic products and method of preparation
ATE386506T1 (en) * 1995-10-17 2008-03-15 Jagotec Ag ADMINISTRATION OF INSOLUBLE DRUGS
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
EP1054678B1 (en) * 1998-02-11 2003-05-28 RTP Pharma Corporation Combination of steroid and polyunsaturated fatty acids for treatment of inflammatory conditions
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
ES2216517T3 (en) 1998-05-29 2004-10-16 Skyepharma Canada Inc. COMPOSITIONS OF THERMOPROTEGED MICROCAPSULES AND PROCEDURE FOR THE TERMINAL STERILIZATION WITH STEAM.
IL141095A0 (en) 1998-08-19 2002-02-10 Rtp Pharma Inc Injectable aqueous dispersions of propofol
AU767154B2 (en) 1998-11-20 2003-10-30 Skyepharma Canada Inc. Dispersible phospholipid stabilized microparticles
EP1214059B1 (en) * 1999-09-21 2005-05-25 Skyepharma Canada Inc. Surface modified particulate compositions of biologically active substances
ES2469642T3 (en) 2000-04-20 2014-06-18 Jagotec Ag Improved procedure for water insoluble drug particles
CN100457090C (en) 2000-08-31 2009-02-04 斯凯伊药品加拿大公司 Grinding particles
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
EP1361867B1 (en) * 2001-02-22 2007-03-21 Jagotec AG Fibrate-statin combinations with reduced fed-fasted effects
MXPA04004726A (en) * 2001-11-19 2004-07-30 Becton Dickinson Co Pharmaceutical compositions in particulate form.
EP2485764A4 (en) * 2009-10-09 2014-01-29 Childrens Medical Center WHOLE CELL VACCINE WITH SELECTIVE DISSOCIATION
CN103386125A (en) * 2012-05-08 2013-11-13 刘江秋 Development of hemorrhagic fever with renal syndrome (HFRS) nasal mucosa immunization aerosol vaccine
CN107475204A (en) * 2017-08-03 2017-12-15 中国人民解放军军事医学科学院军事兽医研究所 A kind of togavirus protective agent and preparation method thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550706A1 (en) * 1983-08-17 1985-02-22 Sterwin Ag
GB2145107A (en) * 1983-08-17 1985-03-20 Sterwin Ag Preparation of aerosol compositions
GB2170815A (en) * 1985-02-05 1986-08-13 Sterwin Ag Aerosol compositions
GB2170815B (en) * 1985-02-05 1989-07-05 Sterwin Ag Aerosol compositions
EP1592443A4 (en) * 2003-02-13 2007-02-21 Becton Dickinson Co Improved anthrax vaccines and delivery methods

Also Published As

Publication number Publication date
NL7012832A (en) 1972-03-02
US3755557A (en) 1973-08-28
DE2141289A1 (en) 1972-03-09
CA971480A (en) 1975-07-22
BE771918A (en) 1972-02-28
FR2103608A1 (en) 1972-04-14
FR2103608B1 (en) 1975-02-07

Similar Documents

Publication Publication Date Title
GB1302671A (en)
AU459399B2 (en) Improvements in or relating tothe production of enzyme preparations
AU1314370A (en) Gas-releasable and foamable compositions
AU464817B2 (en) Improvements in or relating tothe growing of grasses
CA939513A (en) Method for the preparation of charge batches
CA965796A (en) N-n-dialkylamindoxime phosphates and their use as herbicides
CA957827A (en) Preparation of ammonium polythiomolybdate
CA1009657A (en) Method of preparation of 5-fluorouracil
CA965005A (en) Stable oily preparations of epithio-steroids
CA835262A (en) Aqueous dispersions of plasticized nitrocellulose and method of preparing the same
IL36164A (en) Process for the preparation of 17alpha-hydroxy-pregna-4,9(11)-diene-3,20-dione and some new intermediates
CA847310A (en) Antacid preparations and means of producing the same
ZA711290B (en) Novel 16-methylene-9beta,10alpha steroid compounds,pharmaceutical preparations which contain the novel compounds as active ingredients,and methods of producing the said compounds and preparations
ZA714768B (en) Pesticidal preparations containing 3,4-dichlorofuroxan as an active constituent and their use in the control of nematodes and fungi
CA942178A (en) Method and arrangement for drying of dispersions by atomizing
AU433731B2 (en) Improvements in or relating tothe prepar of foams
CA847503A (en) Battery and method of making the same
CA847359A (en) Morpholinoalkyleneindoles and method of preparing the same
CA690034A (en) Tri-(dialkylaminoalkyl) phosphates and the method of their preparation
CA833022A (en) (lower) alkyl esters of 1,4-dihydroquinoline-n-carboxylic acid and 1,4-dihydroquinoline-n-thioncarboxylic acid
CA844612A (en) Water-soluble phosphate compositions and process for preparing
AU458338B2 (en) Preparation of hyperbasic dispersions
CA848949A (en) Process for the isolation of fibrinolytic factor
AU441197B2 (en) Novel thienodiazepines and preparations thereof
CA615368A (en) Amino acid compounds and methods for producing the same

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee